Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Surgery Partners Inc (SGRY) operates a national network of surgical facilities and complementary healthcare services, delivering integrated outpatient care solutions. This page serves as the definitive source for verified company announcements, financial updates, and operational developments.
Key resources for stakeholders include earnings reports, partnership announcements, facility expansions, and regulatory filings. Our curated news collection enables investors to track strategic initiatives in ambulatory surgery centers, diagnostic services, and specialty care programs.
Regular updates cover operational milestones, leadership changes, and industry recognition. All content undergoes strict verification to ensure accuracy and relevance for healthcare investors and sector analysts.
Bookmark this page for streamlined access to SGRY's latest developments in surgical innovation and outpatient care delivery. Combine real-time updates with historical context for informed decision-making.
Surgery Partners (NASDAQ:SGRY) will release its first quarter 2023 results on May 1, 2023, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET. Interested parties can participate via a dial-in number or by accessing a live webcast on the Company's Investor Relations website. Surgery Partners is a prominent healthcare services provider, specializing in outpatient surgical care with over 180 locations across 31 states. The company aims to deliver high-quality, cost-effective solutions in surgical and related ancillary care.
Surgery Partners (SGRY) reported a revenue increase of 15.9% to $707.1 million for Q4 2022 and 14.1% to $2.5 billion for the full year. Despite strong revenue growth, the company faced a net loss of $23.4 million for Q4 2022 and $54.6 million for the full year. Adjusted EBITDA rose by 5.6% to $120.8 million in Q4 and 12.0% to $380.2 million for the full year. The company anticipates 2023 revenues greater than $2.75 billion and Adjusted EBITDA exceeding $425 million.
FAQ
What is the current stock price of Surgery Partners (SGRY)?
What is the market cap of Surgery Partners (SGRY)?
